Moneycontrol
Get App
SENSEX NIFTY
you are here:

Eris Lifesciences Ltd.

BSE: 540596 | NSE: ERIS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE406M01024 | SECTOR: Pharmaceuticals

BSE Live

Apr 01, 16:00
367.35 -1.15 (-0.31%)
Volume
AVERAGE VOLUME
5-Day
380,834
10-Day
211,306
30-Day
89,200
322
  • Prev. Close

    368.50

  • Open Price

    372.40

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Apr 01, 15:57
372.40 3.50 (0.95%)
Volume
AVERAGE VOLUME
5-Day
114,852
10-Day
134,851
30-Day
134,537
18,811
  • Prev. Close

    368.90

  • Open Price

    377.55

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

ANNOUNCEMENTS ON Eris Life

  • Mar 31, 2020 17:26 Source: BSE

    Eris Lifesciences - Closure of Trading Window

    INTIMATION OF CLOSURE OF TRADING WINDOW

  • Mar 24, 2020 14:54 Source: BSE

    Eris Lifesciences - Closure of Trading Window

    We refer to our earlier letter dated 5th March, 2020 regarding ''Consideration of Interim dividend by the Board and other connected matters''. It is hereby notified that considering the availability of all the relevant information pertaining to the said matter being now in the public domain, and also in view of the fact that the ''record date'' in respect thereof having passed as well as completion of more than 48 hours of submission of outcome of Board Meeting held on 11th March, 2020 and in pursuance to the provisions of Code of Conduct of the Company, the trading window closure previously notified to be valid till 31st March 2019, now stands short closed till 24th March 2020. The trading window shall open from 25th March 2020 and shall remain open till the announcement of its next closure.

  • Mar 18, 2020 11:44 Source: NSE

    Eris Lifesciences Limited

    Eris Lifesciences Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

  • Mar 18, 2020 11:04 Source: BSE

    Eris Lifesciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    In accordance with the requirements of Regulation 30 and other applicable Regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, we hereby notify the schedule of Analyst / Institutional Investor Meeting

  • Mar 12, 2020 12:45 Source: NSE

    Eris Lifesciences Limited

    Eris Lifesciences Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

  • Mar 12, 2020 12:18 Source: BSE

    Eris Lifesciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    In accordance with the requirements of Regulation 30 and other applicable Regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, we hereby notify the schedule of Analyst / Institutional Investor Meeting(s)

  • Mar 11, 2020 12:40 Source: NSE

    Eris Lifesciences Limited

    Eris Lifesciences Limited has informed the Exchange that Board of Directors at its meeting held on March 11, 2020, declared Interim Dividend of 2.87 per equity share.

  • Mar 11, 2020 12:23 Source: BSE

    Eris Lifesciences - Board declares Interim Dividend

    Eris Lifesciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 11, 2020 duly approved the declaration of Interim Dividend of Rs. 2.87/- (at the rate of 287%) on each fully paid-up equity share of Re. 1/- for the Financial Year 2019-20.

  • Mar 11, 2020 11:45 Source: BSE

    Eris Lifesciences - OUTCOME OF THE BOARD MEETING HELD TODAY, I.E. March 11, 2020

    The Board of Directors of the Company at their meeting held today i.e. March 11, 2020 duly approved the declaration of Interim Dividend of Rs. 2.87/- (at the rate of 287%) on each fully paid-up equity share of Re. 1/- for the Financial Year 2019-20. We further inform that, the Company has fixed 20th March, 2020 as the record date to determine the names of the equity shareholders, who shall be entitled to receive the payment towards interim dividend for the financial year 2019-20. The payment of the interim dividend would be made to the eligible shareholders on or before 10th April, 2020.

  • Mar 06, 2020 13:09 Source: NSE

    Eris Lifesciences Limited

    Eris Lifesciences Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

BOARD MEETING

Meeting Date : Mar 11, 2020
Remark : Interim Dividend